Get the Stockscreener App
14.50
4.32%
0.60
After Hours:
14.50
Liquidia Corp Stock (LQDA) Latest News
Liquidia Corporation to Report Full Year 2024 Financial Results on March 19, 2025 - GlobeNewswire Inc.
Insider Sell: CFO and COO Michael Kaseta Sells 12,166 Shares of Liquidia Corp (LQDA) - GuruFocus.com
Liquidia’s chief commercial officer sells shares worth $9,146 By Investing.com - Investing.com Canada
Liquidia’s chief commercial officer sells shares worth $9,146 - Investing.com India
Liquidia Corp CFO Michael Kaseta sells shares worth $13,503 - Investing.com
Liquidia Corp Executives Sell Shares - TradingView
FDA Was Right to Delay Approving Liquidia's Yutrepia, Judge Says - Bloomberg Law
Liquidia Corp loses FDA lawsuit; Tyvaso DPI exclusivity stands - Investing.com
Liquidia Challenge To UTC's Tyvaso Exclusivity Fails - Law360
Bleakley Financial Group LLC Lowers Stock Position in Liquidia Co. (NASDAQ:LQDA) - Defense World
The Attractiveness of Investing In Liquidia Corp (LQDA) is Growing - Knox Daily
Liquidia Co. (NASDAQ:LQDA) Receives $25.38 Average Price Target from Brokerages - MarketBeat
Liquidia Corp's chief business officer sells $6,319 in stock - MSN
Life Sciences Group Of The Year: Cooley - Law360
Stock Performance Spotlight: Liquidia Corp (LQDA) Ends the Day at 15.74, Up by 3.89 - The Dwinnex
Liquidia Corp.: We Have Exposure To The Upside Now - Seeking Alpha
Liquidia Corp (LQDA) stock on the rise: An overview - US Post News
Arquitos Capital Management Q4 2024 Commentary - Seeking Alpha
This trade activity should not be overlooked: Liquidia Corp (LQDA) - SETE News
Liquidia Corp [LQDA] Investment Appeal on the Rise - Knox Daily
Liquidia Corporation's Long-Running Saga Is Coming To An End (NASDAQ:LQDA) - Seeking Alpha
Liquidia Corp's chief medical officer sells $31,785 in stock - MSN
Liquidia Co. (NASDAQ:LQDA) Insider Sells $31,785.00 in Stock - MarketBeat
Liquidia Corp's chief medical officer sells $31,785 in stock By Investing.com - Investing.com UK
Liquidia Technologies (LQDA) Moves 5.7% Higher: Will This Strength Last? - Yahoo Finance
Barclays PLC Purchases 72,591 Shares of Liquidia Co. (NASDAQ:LQDA) - Defense World
Liquidia Corp CFO Michael Kaseta sells shares worth $275,298 By Investing.com - Investing.com Australia
Rajeev Saggar Sells 6,249 Shares of Liquidia Co. (NASDAQ:LQDA) Stock - MarketBeat
Roger Jeffs Sells 22,343 Shares of Liquidia Co. (NASDAQ:LQDA) Stock - MarketBeat
Liquidia Co. (NASDAQ:LQDA) General Counsel Russell Schundler Sells 16,393 Shares - MarketBeat
Liquidia's chief medical officer Rajeev Saggar sells $73,613 in stock By Investing.com - Investing.com Australia
Liquidia's chief commercial officer sells shares worth $98,504 By Investing.com - Investing.com Australia
Liquidia’s chief commercial officer sells shares worth $98,504 By Investing.com - Investing.com Nigeria
Liquidia Corp chief business officer sells $56,650 in stock By Investing.com - Investing.com South Africa
Liquidia's chief commercial officer sells shares worth $98,504 - Investing.com India
Liquidia's chief medical officer Rajeev Saggar sells $73,613 in stock - Investing.com India
Liquidia Corp general counsel sells shares worth $193,109 - Investing.com India
Liquidia Corp chief business officer sells $56,650 in stock - Investing.com
Liquidia Corp CFO Michael Kaseta sells shares worth $275,298 - Investing.com
Liquidia Corp general counsel sells shares worth $193,109 By Investing.com - Investing.com UK
Liquidia’s (LQDA) Buy Rating Reiterated at Needham & Company LLC - Defense World
Analysts Set Liquidia Co. (NASDAQ:LQDA) Price Target at $25.38 - MarketBeat
Liquidia's (LQDA) "Buy" Rating Reaffirmed at Needham & Company LLC - MarketBeat
Breaking Down Liquidia: 4 Analysts Share Their Views - Benzinga
Liquidia Corporation to Present at 43rd Annual J.P. Morgan Healthcare Conference - Yahoo Finance
Liquidia CEO to Present at J.P. Morgan Healthcare Conference 2025 in San Francisco - StockTitan
Yutrepia's Launch: A Catalyst for Liquidia (LQDA) - substack.com
Liquidia Co. (NASDAQ:LQDA) Shares Sold by Geode Capital Management LLC - MarketBeat
3.70%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):